Nature Cell begins U.S. phase II trials of arthritis stem cell therapy

Nature Cell begins U.S. phase II trials of arthritis stem cell therapy

Dubbed “Joint Stem,” Nature Cell's new therapy uses about 10 grams of fat tissue extracted from a given patient's glenoid cavity to incubate some 100 million mesenchymal stem cells, which are later compressed into a 3 cubic-centimeters injection.

(Visited 1 times, 1 visits today)
3
Like
Save

Comments

Comments are disabled for this post.